C9ORF72 gene modulators (Scripps/Mayo Clinic)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameC9ORF72 gene modulators (Scripps/Mayo Clinic)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGuanine nucleotide exchange C9orf72 modulators
TargetsGuanine nucleotide exchange C9orf72
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Scripps Research Institute IncMayo Clinic
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia

Other Information

ATC CodeN/A
Related LinksN/A